SEC
Whistleblower
Advocates

March 29, 2016

AVEO Pharmaceuticals, Inc.

Offering Fraud

SANCTION AMOUNT: $4,000,000

Defendants: AVEO Pharmaceuticals, Inc.

Sanction in settlement of allegations that company raised $53 million in a public stock offering while failing to disclose that the FDA had recommended an additional clinical trial for its flagship developmental drug to treat kidney cancer.

Thank you for submitting some email to us.